• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于寻常痤疮的选择性 RAR 激动剂:一项叙述性综述。

Selective RAR agonists for acne vulgaris: A narrative review.

机构信息

Worldwide laser institute, Dallas, TX, USA.

Department of Dermatology, Bangalore Medical College and Research Institute, Bangalore, India.

出版信息

J Cosmet Dermatol. 2020 Jun;19(6):1278-1283. doi: 10.1111/jocd.13340. Epub 2020 Feb 26.

DOI:10.1111/jocd.13340
PMID:32100454
Abstract

BACKGROUND

Acne vulgaris is a chronic disfiguring inflammatory disease of adolescents and adults affecting up to 90% of the population around the world. The sequence of etiopathogenesis in acne is not completely understood but involves abnormalities in sebum production, follicular plugging, proliferation of propionibacterium acnes, and chronic inflammation.

AIMS

This review aims to summarize the features of the topical selective RAR agonists in treating acne vulgaris with a special emphasis on the 4th generation topical retinoid trifarotene.

METHODS

Studies were identified by searching electronic databases (MEDLINE and PubMed) till August 2019 and reference lists of respective articles. Only articles published in English language were included.

RESULTS

Topical retinoids have been first line of treatment for more than 30 years now in treating mild to moderate acne vulgaris. Third generation retinoids like adapalene and tazarotene are selective RAR and γ agonists, having an additional anti-inflammatory action along with their comedolytic effects and work well in combinations with topical antibiotics, due to the stability of chemical composition.

CONCLUSION

Trifarotene is a new 4th generation retinoid with selective action on RAR-γ receptor alone, which is specific for skin, and it is safe for long-term maintenance therapy with good efficacy and tolerability.

摘要

背景

寻常痤疮是一种影响全球多达 90%人群的青少年和成年人慢性毁容性炎症性疾病。痤疮的发病机制尚不完全清楚,但涉及皮脂产生、毛囊堵塞、痤疮丙酸杆菌增殖和慢性炎症的异常。

目的

本综述旨在总结局部选择性 RAR 激动剂治疗寻常痤疮的特点,特别强调第四代局部维 A 酸三呋替恩。

方法

通过搜索电子数据库(MEDLINE 和 PubMed)至 2019 年 8 月,并查阅各自文章的参考文献列表,确定研究。仅纳入以英文发表的文章。

结果

局部维 A 酸类药物作为治疗轻度至中度寻常痤疮的一线药物已有 30 多年的历史。第三代维 A 酸如阿达帕林和他扎罗汀是选择性 RAR 和 γ 激动剂,除了具有溶粉刺作用外,还具有抗炎作用,并且由于其化学组成的稳定性,与局部抗生素联合使用效果良好。

结论

三呋替恩是一种新型第四代维 A 酸,仅对 RAR-γ 受体具有选择性,对皮肤具有特异性,具有良好的疗效和耐受性,可安全用于长期维持治疗。

相似文献

1
Selective RAR agonists for acne vulgaris: A narrative review.用于寻常痤疮的选择性 RAR 激动剂:一项叙述性综述。
J Cosmet Dermatol. 2020 Jun;19(6):1278-1283. doi: 10.1111/jocd.13340. Epub 2020 Feb 26.
2
Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-γ agonist trifarotene.强效和选择性局部维 A 酸受体 γ 激动剂三苯氧胺的非临床和人体药理学研究。
Br J Dermatol. 2018 Aug;179(2):442-456. doi: 10.1111/bjd.16719. Epub 2018 Jul 4.
3
Trifarotene: First Approval.三苯甲维罗:首次批准。
Drugs. 2019 Nov;79(17):1905-1909. doi: 10.1007/s40265-019-01218-6.
4
Changing the face of acne therapy.改变痤疮治疗的面貌。
Cutis. 2009 Feb;83(2 Suppl):4-15.
5
Spotlight on adapalene in acne vulgaris.寻常痤疮中阿达帕林的聚焦
Am J Clin Dermatol. 2004;5(5):369-71. doi: 10.2165/00128071-200405050-00014.
6
Management of Acne Vulgaris With Trifarotene.痤疮的三芳维甲酸治疗管理。
J Cutan Med Surg. 2023 Jul-Aug;27(4):368-374. doi: 10.1177/12034754231163542. Epub 2023 Mar 16.
7
Topical Retinoids in Acne Vulgaris: A Systematic Review.寻常痤疮的局部用维 A 酸类药物:系统评价。
Am J Clin Dermatol. 2019 Jun;20(3):345-365. doi: 10.1007/s40257-019-00423-z.
8
Trifarotene (Aklief) - a new topical retinoid for acne.三氟罗汀(阿克利夫)——一种用于治疗痤疮的新型外用维甲酸类药物。
Med Lett Drugs Ther. 2019 Dec 16;61(1587):195-197.
9
Adapalene: a review of its use in the treatment of acne vulgaris.阿达帕林:用于寻常痤疮治疗的综述
Drugs. 2004;64(13):1465-78. doi: 10.2165/00003495-200464130-00005.
10
Meta-analysis of topical tazarotene in the treatment of mild to moderate acne.外用他扎罗汀治疗轻至中度痤疮的荟萃分析。
Cutis. 2004 Oct;74(4 Suppl):9-15.

引用本文的文献

1
Computational Insights into the Polypharmacological Landscape of BCR-ABL Inhibitors: Emphasis on Imatinib and Nilotinib.BCR-ABL抑制剂多药理学格局的计算洞察:重点关注伊马替尼和尼洛替尼。
Pharmaceuticals (Basel). 2025 Jun 20;18(7):936. doi: 10.3390/ph18070936.
2
Structural requirement of RARγ agonism through computational aspects.通过计算方面对维甲酸受体γ(RARγ)激动作用的结构要求
J Mol Model. 2023 Mar 24;29(4):108. doi: 10.1007/s00894-023-05507-6.
3
Management of Acne Vulgaris With Trifarotene.痤疮的三芳维甲酸治疗管理。
J Cutan Med Surg. 2023 Jul-Aug;27(4):368-374. doi: 10.1177/12034754231163542. Epub 2023 Mar 16.
4
Prediction and Demonstration of Retinoic Acid Receptor Agonist Ch55 as an Antifibrotic Agent in the Dermis.预测并验证维甲酸受体激动剂 Ch55 在真皮组织中的抗纤维化作用。
J Invest Dermatol. 2023 Sep;143(9):1724-1734.e15. doi: 10.1016/j.jid.2023.01.024. Epub 2023 Feb 17.
5
Retinoids in Fungal Infections: From Bench to Bedside.用于真菌感染的维甲酸:从实验台到病床
Pharmaceuticals (Basel). 2021 Sep 24;14(10):962. doi: 10.3390/ph14100962.
6
Endocrine Disrupting Chemicals, Hormone Receptors, and Acne Vulgaris: A Connecting Hypothesis.内分泌干扰化学物质、激素受体与寻常痤疮:一个关联假说。
Cells. 2021 Jun 9;10(6):1439. doi: 10.3390/cells10061439.
7
Recent Advances Regarding the Therapeutic Potential of Adapalene.关于阿达帕林治疗潜力的最新进展
Pharmaceuticals (Basel). 2020 Aug 28;13(9):217. doi: 10.3390/ph13090217.
8
Orobol, A Derivative of Genistein, Inhibits Heat-Killed -Induced Inflammation in HaCaT Keratinocytes.染料木黄酮衍生物 Orobol 抑制热灭活诱导的 HaCaT 角质形成细胞炎症。
J Microbiol Biotechnol. 2020 Sep 28;30(9):1379-1386. doi: 10.4014/jmb.2003.03063.